SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 275 filers reported holding SAGE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $237,000 | -74.8% | 3,282 | -51.1% | 0.01% | -78.1% |
| Q3 2019 | $942,000 | -20.6% | 6,716 | +3.7% | 0.03% | -25.6% |
| Q2 2019 | $1,186,000 | +10.1% | 6,476 | -4.4% | 0.04% | +4.9% |
| Q1 2019 | $1,077,000 | +206.8% | 6,771 | +84.5% | 0.04% | +156.2% |
| Q4 2018 | $351,000 | -51.1% | 3,669 | -27.9% | 0.02% | -38.5% |
| Q3 2018 | $718,000 | -5.3% | 5,086 | +5.0% | 0.03% | -10.3% |
| Q2 2018 | $758,000 | +88.1% | 4,844 | +98.0% | 0.03% | +81.2% |
| Q4 2017 | $403,000 | – | 2,447 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Rock Ventures, LLC | 9,773,073 | $490,901,000 | 52.36% |
| Ghost Tree Capital, LLC | 240,000 | $12,056,000 | 2.17% |
| EcoR1 Capital, LLC | 112,455 | $5,649,000 | 1.88% |
| New Leaf Venture Partners, L.L.C. | 43,770 | $2,199,000 | 1.49% |
| AlpInvest Partners B.V. | 12,195 | $613,000 | 1.15% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 595,443 | $29,909,000 | 0.97% |
| APEX CAPITAL, LLC | 190,000 | $9,544,000 | 0.69% |
| OAK RIDGE INVESTMENTS LLC | 385,770 | $19,377,000 | 0.43% |
| Lombard Odier Asset Management (USA) Corp | 92,089 | $4,626,000 | 0.37% |
| SPHERA FUNDS MANAGEMENT LTD. | 65,724 | $3,301,000 | 0.34% |